Published ahead of print on September 15, 2005, doi:10.1164/rccm.200506-888OC Am. J. Respir. Crit. Care Med., Volume 172, Number 11, December 2005, 1440-1446 A more recent version of this article appeared on December 1, 2005
Submitted on June 8, 2005 Pre-Infection Systemic Inflammatory Markers and Risk of Hospitalization due to PneumoniaSachin Yende1*,1 Department of Critical Care Medicine, The University of Pittsburgh, CRISMA Laboratory, Pittsburgh, PA, USA, 2 Department of Infectious Diseases, St. Jude's Children's Research Hospital, Memphis, TN, USA, 3 Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL, USA, 4 Division of General Internal Medicine, University of California, San Francisco, CA, USA, 5 Department of Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA, 6 National Institute of Aging, Bethesda, MD, USA, 7 Laboratory of Epidemiology, Demography and Biometry, National Institute of Aging, Bethesda, MD, USA, 8 Sticht Center on Aging, Wake Forest University School of Medicine, Winston-Salem, NC, USA * To whom correspondence should be addressed. E-mail: yendes{at}upmc.edu.
Rationale: Elevated pro-inflammatory cytokines are associated with severity of pneumonia, but the role of pre-infection cytokine levels in the predisposition to pneumonia in humans is less clear.
Objective: To ascertain role of pre-infection inflammatory markers on susceptibility to Community-acquired pneumonia(CAP).
Methods: Longitudinal analysis over 6.5 years of a cohort that consists of 70-79 year well-functioning elderly.
Measurements: Association between pre-infection tumor necrosis factor (TNF), interleukin-6 (IL-6), and C-reactive protein (CRP) levels and CAP requiring hospitalization.
Results: Of the 3075 participants, 161 (5.2%) developed at least one episode of CAP requiring hospitalization over a median duration of 3.3 years. The highest tertiles of TNF (>3.7pg/ml) and IL-6 (>2.4pg/ml) were associated with increased risk of CAP, and the adjusted odds ratios were 1.6 (95% confidence interval [CI]=1.02-2.7) and 1.7(95% CI=1.1-2.8), respectively. The adjusted risk of CAP with at least one of these markers in the highest tertile was 1.6 (95%CI=1.1-2.3). TNF and IL-6 levels in the highest tertile had a synergistic effect (P=0.01 for interaction), and risk of CAP for both markers in the highest tertile was 2.8 (95%CI=1.8-4.3). A FEV1 Key words: Pneumonia, inflammatory markers, tumor necrosis factor, interleukin-6
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||